Showing results (2831-2840 of 6,517) with videos related to
Sort By:
Pageof 652
Cancer Immunology, Immunotherapy : CII|September 9, 2019
Presence of T cells directed against CD20-derived peptides in healthy individuals and lymphoma patientsBenoit Milcent, Nathalie Josseaume, Quentin Riller, et al.Cancer Immunology, Immunotherapy : CII|February 26, 2021
Simultaneously target of normal and stem cells-like gastric cancer cells via cisplatin and anti-CD133 CAR-T combination therapyYang Han, Bo Sun, Hong Cai, et al.Cancer Immunology, Immunotherapy : CII|February 12, 2021
PD-L1 amplification is associated with an immune cell rich phenotype in squamous cell cancer of the lungTorsten Goldmann, Sebastian Marwitz, Dörte Nitschkowski, et al.Cancer Immunology, Immunotherapy : CII|February 13, 2021
Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trialKjetil Boye, Alessandra Longhi, Tormod Guren, et al.Cancer Immunology, Immunotherapy : CII|February 5, 2021
Interleukin-7-loaded oncolytic adenovirus improves CAR-T cell therapy for glioblastomaJianhan Huang, Meijun Zheng, Zongliang Zhang, et al.Cancer Immunology, Immunotherapy : CII|December 4, 2016
Preventive DNA vaccination against CEA-expressing tumors with anti-idiotypic scFv6.C4 DNA in CEA-expressing transgenic micePriscila M A Denapoli, Bianca F Zanetti, Adara A Dos Santos, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1989
Factors influencing antibody-mediated cytotoxicity during the immunotherapy of Rauscher-virus-induced myeloid leukemic cellsD Berends, T H van der Kwast, N J de Both, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1989
Influence of the donors' clinical status on in vitro and in vivo tumor-cytotoxic activation of interleukin-2-exposed lymphocytes and their circulation in different organsM Rodolfo, C Salvi, G ParmianiCancer Immunology, Immunotherapy : CII|January 1, 1989
Recombinant human tumor necrosis factor mediates regression of a murine sarcoma in vivo via Lyt-2+ cellsA L Asher, J J Mulé, S A RosenbergCancer Immunology, Immunotherapy : CII|January 1, 1989
Effect of anticancer agents neothramycin, aclacinomycin, FK-565 and FK-156 on the release of interleukin-2 and interleukin-1 in vitroK Ahmed, J L TurkPageof 652